Serum Fibroblast Growth Factor-21 Is Related to Atherosclerosis Independent of Nonalcoholic Fatty Liver Disease and Predicts Incident Atherosclerotic Cardiovascular Diseases

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 166-OR
Author(s):  
LIANG WU ◽  
LINGLING QIAN ◽  
HUATING LI ◽  
WEIPING JIA
Keyword(s):  
Liver Disease ◽  
Cardiovascular Diseases ◽  
Growth Factor ◽  
Fatty Liver ◽  
Fibroblast Growth Factor ◽  
Fatty Liver Disease ◽  
Fibroblast Growth Factor 21 ◽  
Fibroblast Growth ◽  
Nonalcoholic Fatty Liver ◽  
Atherosclerotic Cardiovascular Diseases

scholarly journals Increased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty Liver Disease

2010 ◽  
Vol 139 (2) ◽  
pp. 456-463 ◽  
Author(s):  
Jody Dushay ◽  
Patricia C. Chui ◽  
Gosala S. Gopalakrishnan ◽  
Marta Varela–Rey ◽  
Meghan Crawley ◽  
...  
Keyword(s):  
Liver Disease ◽  
Growth Factor ◽  
Fatty Liver ◽  
Nonalcoholic Fatty Liver Disease ◽  
Fibroblast Growth Factor ◽  
Fatty Liver Disease ◽  
Fibroblast Growth Factor 21 ◽  
Fibroblast Growth ◽  
Nonalcoholic Fatty Liver

Fibroblast growth factor 21 in non-alcoholic fatty liver disease

Metabolism ◽  
2019 ◽  
Vol 101 ◽  
pp. 153994 ◽  
Author(s):  
Bradley Tucker ◽  
Huating Li ◽  
Xiaoxue Long ◽  
Kerry-Anne Rye ◽  
Kwok Leung Ong
Keyword(s):  
Liver Disease ◽  
Growth Factor ◽  
Fatty Liver ◽  
Fibroblast Growth Factor ◽  
Fatty Liver Disease ◽  
Fibroblast Growth Factor 21 ◽  
Fibroblast Growth ◽  
Alcoholic Fatty Liver ◽  
Alcoholic Fatty Liver Disease
Sign in / Sign up

Export Citation Format

Share Document